Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thale D J H Patrick-Brown

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Trials|January 3, 2024
Experiences and challenges with the new European Clinical Trials RegulationThale D J H Patrick-Brown, Josephine Bourner, Sabrina Kali, et al.
Pleura and Peritoneum|April 6, 2023
Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritoneiThale D J H Patrick-Brown, Faheez Mohamed, Andrew Thrower, et al.
Critical Care (London, England)|January 10, 2023
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trialMarius Trøseid, José R Arribas, Lambert Assoumou, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Trials|January 3, 2024
Experiences and challenges with the new European Clinical Trials RegulationThale D J H Patrick-Brown, Josephine Bourner, Sabrina Kali, et al.
Pleura and Peritoneum|April 6, 2023
Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritoneiThale D J H Patrick-Brown, Faheez Mohamed, Andrew Thrower, et al.
Critical Care (London, England)|January 10, 2023
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trialMarius Trøseid, José R Arribas, Lambert Assoumou, et al.
Pageof 1